Graft fibrosis in stable pediatric liver transplant recipients: What does it mean?

Hepatology

Volumn 49, Issue 3, 2009, Pages 726-728

  Magee, John C ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 10; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ALLOIMMUNITY; ARTICLE; BILE DUCT ATRESIA; CD4+ CD25+ T LYMPHOCYTE; DISEASE SEVERITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE OVEREXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; T LYMPHOCYTE; ADOLESCENT; AGE; CHILD; DISEASE COURSE; IMMUNOLOGY; INFANT; LIVER CIRRHOSIS; NOTE; PATHOLOGY; PRESCHOOL CHILD; RISK FACTOR; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; HUMANS; IMMUNOSUPPRESSION; INFANT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PREVALENCE; RISK FACTORS; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 63349100330     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22864     Document Type: Article

References (26)

1. Magee JC, Bucuvalas JC, Farmer DG, Harmon WE, Hulbert-Shearon TE, Mendeloff EN. Pediatric transplantation. Am J Transplant 2004;4:54-71.
2. Soltys KA, Mazariegos GV, Squires RH, Sindhi RK, Anand R, and the SPLIT Research Group. Late graft loss or death in pediatric liver transplantation: An analysis of the SPLIT database. Am J Transplant 2007;7:2165-2171.
3. Bucuvalas JC, Alonso E, Magee JC, Talwalkar J, Hanto D, Doo E. Improving long-term outcomes after liver transplantation in children. Am J Transplant 2008;8:2506-2513.
4. Ng VL, Fecteau A, Shepherd R, Magee J, Bucuvalas J, Alonso E, et al. Outcomes of 5-year survivors of pediatric liver transplantation: Report on 461 children from a North American multicenter registry. Pediatrics 2008; 122:e1128-e1135.
5. Scheenstra R, Peeters PMGJ, Verkade HJ, Gouw ASH. Graft fibrosis after pediatric liver transplantation: Ten years of follow-up. HEPATOLOGY 2008; doi: 10.1002/hep.22686.
6. Peeters PM, Sieders E, vd Heuvel M, Bijleveld CM, de Jong KP, Ten-Vergert EM, et al. Predictive factors for portal fibrosis in pediatric liver transplant recipients. Transplantation 2000;70:1581-1587.
7. Sebagh M, Rifai K, Feray C, Yilmaz F, Falissard B, Roche B, et al. All liver recipients benefit from the protocol 10-year liver biopsies. HEPATOLOGY 2003;37:1293-1301.
8. The Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction. HEPATOLOGY 2006;44:489-501.
9. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. HEPATOLOGY 2000; 31:792-799.
10. Rosenthal P, Emond JC, Heyman MB, Snyder J, Roberts J, Ascher N, et al. Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients. Liver Transpl Surg 1997;3:559-562.
11. Fouquet V, Alves A, Branchereau S, Grabar S, Debray D, Jacquemin E, et al. Long-term outcome of pediatric liver transplantation for biliary atresia: A 10-year follow-up in a single center. Liver Transpl 2005;11:152-160.
12. Evans HM, Kelly DA, McKiernan PJ, Hubscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. HEPATOLOGY 2006;43:1109-1117.
13. Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, et al. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: A long-term analysis. Transplantation 2003;75:1020-1025.
14. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002;346:580-590.
15. Glanemann M, Langrehr JM, Stange BJ, Neumann U, Settmacher U, Steinmuller T, et al. Clinical implications of hepatic preservation injury after adult liver transplantation. Am J Transplant 2003;3:1003-1009.
16. Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Non-compliance in children post-liver transplant. Who are the culprits? Pediatr Transplant 2004;8:233-236.
17. Horslen S, Barr ML, Christensen LL, Ettenger R, Magee JC. Pediatric transplantation in the United States, 1996-2005. Am J Transplant 2007; 7(5 Pt 2):1339-1358.
18. Racanelli V, Rehermann B. The liver as an immunological organ. HEPATOLOGY 2006;43(Suppl):S54-S62.
19. Kang SM, Tang Q, Bluestone JA. CD4+CD25+ regulatory T cells in transplantation: Progress, challenges and prospects. Am J Transplant 2007; 7:1457-1463.
20. Waldmann H, Graca L, Cobbold S, Adams E, Tone M, Tone Y. Regulatory T cells and organ transplantation. Semin Immunol 2004;16:119-126.
21. Asseman C, Mauze S, LeachMW,Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
22. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 1996;183:2669-2674.
23. Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. HEPATOLOGY 2007;45: 1538-1546.
24. Koshiba T, Li Y, Takemura M, Wu Y, Sakaguchi S, Minato N, et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 2007; 17:94-97.
25. Ganschow R, Broering DC, Nolkemper D, Albani J, Kemper MJ, Rogiers X, et al. Th2 cytokine profile in infants predisposes to improved graft acceptance after liver transplantation. Transplantation 2001;72:929-934.
26. Yang J, Brook MO, Carvalho-Gaspar M, Zhang J, Ramon HE, Sayegh MH, et al. Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci U S A 2007;104:19954-19959.